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ABSTRACT
Although DNA flexibility is known to play an import-
ant role in DNA–protein interactions, the importance
of protein flexibility is less well understood. Here, we
show that protein dynamics are important in DNA
recognition using the well-characterized human
papillomavirus (HPV) type 6 E2 protein as a model
system. We have compared the DNA binding
properties of the HPV 6 E2 DNA binding domain
(DBD) and a mutant lacking two C-terminal leucine
residues that form part of the hydrophobic core of
the protein. Deletion of these residues results in
increased specific and non-specific DNA binding
and an overall decrease in DNA binding specificity.
Using 15N NMR relaxation and hydrogen/deuterium
exchange, we demonstrate that the mutation results
in increased flexibility within the hydrophobic core
and loop regions that orient the DNA binding
helices. Stopped-flow kinetic studies indicate that
increased flexibility alters DNA binding by
increasing initial interactions with DNA but has
little or no effect on the structural rearrangements
that follow this step. Taken together these data
demonstrate that subtle changes in protein
dynamics have a major influence on protein–DNA
interactions.
INTRODUCTION
The recognition of speciﬁc DNA sequences by proteins is
required for gene transcription, DNA replication and all
other processes that involve the manipulation of DNA.
Although the structural and mechanistic properties of
many protein–DNA complexes have been studied in ﬁne
detail, we still lack a thorough understanding of the role of
protein and DNA ﬂexibility in sequence recognition. The
papillomavirus E2 proteins have provided several
important insights into speciﬁc and non-speciﬁc DNA
binding and the role of DNA ﬂexibility in protein–DNA
interactions (1,2). The E2 proteins from several human
papillomavirus (HPV) types including HPV 6, 16 and 18
have been studied in molecular detail as has the bovine
papillomavirus (BPV) E2 protein (1).
The E2 proteins comprise an N-terminal transcription
regulatory domain and a C-terminal DNA binding
domain (DBD) separated by a spacer or hinge region
that is thought to be largely unstructured (3). The DBD
functions as an obligate dimer forming monomers only
after denaturation (4). The DBD binds to inverted
repeats with the consensus sequence:
7654321
50 -AACCGNNNNCGGTT-30
30 -TTGGANNNNGCCAA-50
+1234567
where the 50-AACCG-30 motif and its symmetrically
related inverted repeat 50-CGGTT-30 represent the core
E2 binding site and N4 represents a 4 bp spacer of
variable sequence (5,6). The two subunits of the DBD
form a b-barrel that supports two pairs of surface
exposed a-helices (7). One pair of symmetrically pos-
itioned a-helices make sequence-speciﬁc contacts with
the exposed edges of core E2 binding site base pairs in
two successive major grooves of the DNA (7). Although
the DBD does not contact the base pairs in the spacer
region there can be electrostatic interactions between a
surface exposed loop that links the b2- and b3-strands in
the protein and the DNA backbone, and the nature of the
spacer region has a profound inﬂuence on the ability of E2
proteins to bind DNA (8). The HPV 16 DBD binds with
high afﬁnity to E2 sites that contain a spacer sequence rich
in A:T base pairs but binds with much lower afﬁnity to E2
sites that contain a spacer sequence rich in G:C base pairs
(8,9). This preference for E2 sites with an A:T rich spacer
sequence is even more marked for the HPV 6 E2 protein
(10). In contrast, the BPV E2 protein shows little
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preference for an A:T rich spacer sequence (8). This
indirect readout of the spacer sequence is believed to
arise at least in part from differences in the intrinsic
conformational freedom of different DNA sequences
(11,12). E2 sites with an A:T rich spacer are intrinsically
preferentially bent towards the major groove whereas
those with a G:C rich spacer sequence are predominantly
unbent (11,12). In both crystallographic and solution
studies of E2-DNA complexes, the bound DNA is bent
between 30 and 50 from linear and bending facilitates
penetration of the DNA recognition helices into the DNA
major grooves (5,7,13). The intrinsic DNA bending
associated with E2 sites with an A:T rich spacer is
presumed to be entropically favourable for complex
formation (10). In addition, DNA bending results in
wrapping of the DNA around the protein allowing
extended contacts to be formed (5,10).
Conformational changes within the E2 DBD also occur
on complex formation (14–16). In the BPV E2-DNA
complex, the b2/b3-loop which is unstructured and
presumed mobile in the free protein, adopts a discrete
conformation in contact with DNA backbone phosphates
in the spacer region (7). Similarly, the HPV 16 E2
b2/b3-loop makes electrostatic contacts with the
phosphate backbone in the spacer region upon complex
formation (17). This suggests that these proteins undergo
localized folding or loop rearrangements that favour
DNA binding. The relative orientation of the recognition
helices from these proteins also change on complex
formation (2,13,18). However, this re-orientation is not
observed for the HPV 6 E2 recognition helices and the
HPV 6 E2 b2/b3-loop is ordered in both the presence
and absence of bound DNA (10,13). Recent NMR and
molecular dynamics studies have indicated that in
solution both the HPV 16 and BPV proteins contain a
ﬂexible b2/b3-loop and in the case of the BPV protein,
there is ﬂexibility in the loop connecting a2–b4 and in
the b-barrel. These differences in dynamics have been
suggested to be the basis for differences in protein adapt-
ability and hence DNA recognition (15,19,20). The HPV
6 b-barrel is formed around a network of hydrophobic
side chains that includes two C-terminal leucine residues,
L367 and L368 (Figure 1A) that are not present in most
other E2 proteins (6). We hypothesized that removal of
these residues (and hence four side-chains from the hydro-
phobic core of the DBD) would alter the dynamics within
the E2 dimer and thereby modulate the DNA binding
activity of this protein. Here, we show that a mutated
protein lacking these residues has increased ﬂexibility
and increased afﬁnity for both speciﬁc and non-speciﬁc
DNA.
MATERIALS AND METHODS
Plasmids used in this study
Plasmid pKK223-3-HPV 6 E2 expresses the HPV 6
E2 DBD (amino acids 281–368) and has been described
previously (10). To produce the truncated HPV 6 E2LL
protein the C-terminal leucine residues in the HPV 6 E2
DBD (amino acids L367 and L368) were deleted by the
introduction of a stop codon at position 367 using
a QuickChange mutagenesis kit (Stratagene) according
to the manufacturer’s instructions.
Protein labelling and puriﬁcation
The unlabelled E2 DBD proteins used in this study were
expressed in Escherichia coli XL1 blue cells and puriﬁed to
homogeneity as described previously (10). In brief, the
proteins were puriﬁed over an SP-sepharose column
followed by further fractionation on a MonoS 5/5
column and ﬁnal puriﬁcation using a Heparin column.
Bound proteins were eluted using a 0.0–1.5M NaCl
gradient. The puriﬁed proteins were dialysed against
PBS containing 1mM dithiothreitol (DTT), snap frozen
in liquid nitrogen and stored at 70C until required.
Protein concentration was determined from the OD280nm
using the molar extinction coefﬁcient and activity was
determined using gel retardation assays. Proteins uniform-
ly labelled with 15N or 15N and 13C were produced by
growing the bacteria in M9 minimal media containing
15NH4Cl or
15NH4Cl and
13C glucose as the sole
nitrogen and carbon sources. The labelled proteins were
puriﬁed as above.
NMR
Sample conditions and assignment. Triple resonance NMR
data were acquired at 30C on a Varian INOVA spectrom-
eter operating at 600MHz with a room temperature
probe. Samples were typically 1–2mg/ml (0.1–0.2mM)
and buffer conditions were 50mM NaAc, 25mM KCl,
5mM DTT, pH 5.6. Standard triple resonance
experiments [HNCA, HN(CO)CA, HNCACB,
CBCA(CO)NH, HNCO] were collected for backbone as-
signment of the wild-type HPV 6 E2. Assignment of the
HPV 6 E2LL were completed using a sample of uni-
formly 15N-labelled protein and assignments made using
15N-edited NOESY and TOCSY three-dimensional (3D)
data sets. The chemical shift perturbation was calculated
according to the equation: dav={0.5[d (
1HN)
2+ (0.2
d (15N))2]}1/2 (21).
Relaxation studies. 15N-T1, T2 and
1H-15N NOE relax-
ation data were acquired on a Varian VNMRS
600MHz spectrometer equipped with a salt-tolerant
cryogenically cooled probe-head (22). Protein concentra-
tions were 1–2mg/ml and all spectra were recorded at
30C and sensitivity was maximized by recording
spectra in 3 6mm S-tubes. Buffer conditions were iden-
tical to those used in the chemical shift assignment. T1
delays of 11.1, 33.3, 55.5, 111.0, 199.8, 333, 499.5, 666,
832.5ms and T2 delays of 16.6, 33.2, 49.9, 66.6, 83.2,
99.8, 116.5, 133.1, 149.8, 166.4ms were utilized. 1H-15N
NOEs were measured by recording HSQC spectra with
and without proton saturation. The spectra without
NOE were recorded with delays of 5 s and spectra with
NOE used 3 s of proton saturation and 2 s of delay to
give the same total delay of 5 s between transients. T1
and T2 values were obtained by non-linear least squares
ﬁts of the amide cross peak intensities to a
two-parameter exponential decay. Uncertainties in the
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T1 and T2 values were estimated from non-linear least
squares ﬁts. Uncertainties in the NOE values were
estimated from the base plane noise in 2D 1H-15N
HSQC spectra recorded with and without proton satur-
ation according to Farrow et al. (22).
Model free analysis of the relaxation data was
performed using the two-time-scale Lipari–Szabo
spectral density [Equation (1)] (23,24).
Jð!Þ ¼ 2=5ðS2c=ð1+ð!cÞ2Þ+ð1 S2Þ=ð1+ð!Þ2ÞÞ; ð1Þ
Figure 1. Biochemical and NMR characterization of HPV 6 E2 and E2LL. (A) The HPV 6 E2 b-barrel from PDB 1R8H visualized using PyMol
(41). Residues L367 and L368 are highlighted in red. (B) Samples of the puriﬁed HPV 6 E2 and HPV 6 E2LL proteins were analysed by SDS–
PAGE. The sizes of the markers used are indicated to the left of the gel. (C) Comparison of 1H-15N HSQC spectra of the 6 E2 proteins. The 1H-15N
spectra of 6 E2 (black) and E2LL (orange) are superimposed. Peaks that show large chemical shift perturbations between the two forms are
connected with a line. (D) Chemical shift perturbations (dav) between 6 E2 and E2LL plotted versus sequence number.
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where tc is the overall correlation time (isotropic tumbling
is assumed), S2 is the order parameter, t1= tc
1+te
1,
and te is the effective correlation time describing fast
internal motions. Model free parameters were obtained
from the experimental data by minimizing a target
function describing the differences between experimental
relaxation parameters and relaxation parameters
calculated from the spectral density functions for
the 15N-T1, T2 and
1H-15N NOE values (23,24).
These included S2  c,S2  c  e,S2  c  Rex and
S2  c  e  Rex and a two-time scale model were ﬁtted
to the data (25). All models were ﬁtted using the
programme Modelfree 4.15 (26).
For H/D exchange experiments, freshly lyophilized
samples of 15N-labelled HPV 6 E2 and E2LL were
dissolved in 99.98% D2O and the same buffer used for
assignment and structural studies. The concentration of
E2LL (1.0mg/ml) was estimated to be about twice
that of HPV 6 E2. A series of 1H-15N HSQC spectra
were recorded within 5–7min of dissolving in buffer.
A total of 18 spectra were recorded (128 complex points
in t1, four scans) over the ﬁrst 180min, followed by
64 spectra (128 complex points, eight scans) over the fol-
lowing 21 h, followed by a series of 36 spectra (12 scans)
over the ﬁnal 24 h. The spectra were processed in
NMRPipe and multiple spectra picked using the
programme Analysis (27). Amide exchange rates were
calculated by ﬁtting the decay of amide intensities with a
single-exponential decay curve for well-resolved peaks in
the spectra.
Gel retardation assays
Oligonucleotides with consensus E2 binding sites and A:T
rich or G:C rich spacer sequences used in this work are
shown below; the E2 core sites are underlined and the
central spacer regions are highlighted in bold. Only the
top strands are shown for clarity:
AT 50-ACTAAGGGCGTTGAACCGAATTCGGTTAGTATAAAA
GCAG-30
GC 50-ACTAAGGGCGTTGAACCGCCGGCGGTTAGTATAAAA
GCAG-30
The non-speciﬁc DNAs used in the work were a 195 bp
SphI-BamHI DNA fragment corresponding to sequences
from 3913 to 3718 relative to the start of exon 1 in the
human Vegf promoter and the short non-speciﬁc
oligonucleotide shown below:
NS 50-AGCTTCTGGGAAGCAATTAAAAAATGGCTCGAGCT-30
Single-stranded oligonucleotides (200 ng) were labelled
with [g32]P ATP using T4 polynucleotide kinase.
Double-stranded labelled DNA was then prepared by an-
nealing complementary oligonucleotides by cooling from
90C to 20C over 4 h. The 195 bp non-speciﬁc DNA
fragment was labelled with [a32]P ATP using Klenow
enzyme. Unincorporated ATP was removed using Micro
Bio-Spin 6 columns (Bio-Rad) and labelled DNAs (5000
cpm) were incubated with puriﬁed proteins in 20mM
HEPES pH 7.9, 150mM KCl, 5mM MgCl2, 5mM
dithiothreitol, 0.1% Nonidet P40, 10% glycerol and
0.5 mg/ml bovine serum albumin. After 20min at 20C
free and bound labelled DNA were resolved on
6% non-denaturing polyacrylamide gels run in 1 TBE.
The DNA was visualized and quantiﬁed using a
PhosphorImager with Molecular Dynamics ImageQuant
software (version 3.3). All experiments were repeated at
least ﬁve times. The apparent equilibrium constant
(Keq(apparent)) was obtained using the equation below
[Equation (2)] and Graﬁt4 software (Erithacus Software,
Staines, UK):
½boundDNA ¼ ½MaxboundDNA½proteinð½protein+ðKeqðapp arentÞÞÞ ; ð2Þ
Since the concentration of labelled DNA (<100 pM) is
much lower than Keq the apparent equilibrium constant
is equal to the protein concentration at half maximum
DNA binding.
Solution-binding studies
Stopped-ﬂow kinetic analysis experiments were per-
formed as described previously (13) by monitoring tryp-
tophan ﬂuorescence at 320 nm after excitement at 285 nm
(Applied Photophysics SpectraKinetic Monochromator
and Workstation). The concentration of E2 was kept
constant at either 0.05, 0.2 or 0.5 mM and the concentra-
tion of the A:T rich oligonucleotide was varied from 0.5-
to 20-fold protein concentration. The experiments were
performed in 50mM sodium phosphate, 150mM NaCl
and 2mM dithiothreitol and the stopped ﬂow chamber
was kept at a constant temperature of 25C. Around 25
sets of data were obtained for each condition. The
averaged data were analysed using Graﬁt4 (Erithacus
Software, Staines, UK) and ﬁtted to a double
exponential curve with offset according to the equation
[Equation (3)]:
y ¼ A1  ð1 eðk1tÞÞ+A2  ð1 eðk2tÞÞ+c, ð3Þ
where A1=amplitude 1, A2=amplitude 2, k1= fast rate,
k2=slow rate and c=offset.
The rates obtained from the double exponential curve
were plotted against the DNA concentration and ﬁtted to
a straight line ﬁt for both the slow and the fast rate.
RESULTS AND DISCUSSION
The HPV 6 DBD is rigid in solution
We truncated the HPV 6 E2 DBD by removing the two
C-terminal leucine residues L367 and L368. The
truncated HPV 6 E2LL protein was successfully
produced in bacteria and puriﬁed to homogeneity
(Figure 1B). The truncated protein was readily soluble
suggesting that it is properly folded. To compare the
rigidity of the wild-type and mutated DBDs, we aimed
to study the backbone 15N relaxation of both proteins.
We therefore produced 15N and 15N/13C-labelled HPV 6
E2 and 15N-labelled E2LL for dynamics and chemical
shift assignment. The 1H-15N HSQC spectra of both
HPV 6 E2 and E2LL show good chemical shift disper-
sion and a single set of resonances (Figure 1C)
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corresponding to the dimeric species at a range of protein
concentrations. This is as expected since high concentra-
tions of urea or other denaturants are required to form
monomeric E2 species (4,5,28) and under the conditions
used here these proteins form only dimers. The backbone
chemical shifts of 6 E2 were assigned using standard
triple resonance experiments and transferred to the
E2LL mutant using 15N-edited NOESY and TOCSY
3D data sets. Complete assignments could not be made
for residues H328 through to H330 in the latter half of
the b2/b3-loop due to peak broadening and a lack of
correlations in the triple resonance spectra. Similarly
missing assignment data was reported over most of the
b2/b3-loop for the related HPV 16 DBD (29).
A superposition of the 1H-15N HSQC spectra for 6 E2
and E2LL is shown in Figure 1C. The majority of peaks
show identical or very similar chemical shifts in both
forms of the protein. Therefore despite the deletion of
hydrophobic core residues, the overall structure of the
protein appears to have remained intact. Leucine 368,
which is clearly resolved and circled in Figure 1C, has
no corresponding peak in the mutant form as expected.
Only approximately 15 backbone residues show chemical
shift perturbations (dav) >0.5 ppm (21) and these are
predominantly residues on b1 and b4 that are in direct
contact or adjacent in the structure to the leucine
deletion (Figure 1D). F362 and M363 both show signiﬁ-
cant chemical shift changes that may result from some loss
of structure in b4, which in turn appears to affect residues
285–290 in b1. The remainder of the larger chemical shift
perturbations reside in the b2/b3-loop that packs against
the leucine residues in the wild-type protein and which
also makes contacts with b1.
The reasonable chemical shift dispersion of the E2
spectra allowed the backbone amide relaxation rates to
be measured for 59 residues in wild-type E2 (69.4% of
residues not including prolines or the N-terminal N279)
and 66 residues in E2LL (79.5%). The overall correl-
ation time was determined independently for both E2
and E2LL at 600MHz. Initially an optimal c was
calculated on a per residue basis by minimizing the differ-
ence between the experimental and the calculated T1, T2
and NOE using the isotropic spectral density function
given by Equation (1). Once optimum c values were
calculated for each residue, an optimum average c was
calculated. c was determined to be 9.9 ns and was identi-
cal for both proteins.
From the measured T1, T2 and NOE relaxation
data, parameters that describe the internal motions of 6
E2 were determined using the model-free analysis under
the assumption of isotropic tumbling (23,24). Appropriate
models of spectral density functions were selected for each
residue. These included S2  c,S2  c  e,S2  c  Rex
and S2  c  e  Rex models and a two-time scale model
(25,30) as deﬁned in the ‘Materials and Methods’ section.
T1, T2 and NOE data are shown in Figure 2A–C. In
general, there is good agreement of relaxation parameters
over equivalent residues with the exception of residues
at the N- and C-termini and in the b2/b3-loop. The
backbone 15N relaxation data were interpreted with
the Lipari–Szabo method (23,24) that uses a model
independent formalism and is expressed in terms of a
generalized order parameter S2 that describes the degree
of spatial restriction of a bond vector. Values of S2 >0.9
are indicative of essentially static structures (on the nano-
second timescale), whereas lower values generally indicate
increasing mobility. Relaxation data were ﬁtted with a
number of motional models and the S2 determined for
each residue (Figure 2D). For those residues that did
not ﬁt well to the S2  c or S2  c  e models, alterna-
tive models were assumed (i.e. S2  c  e  Rex and the
two-time-scale model) according to the criteria of Farrow
et al. (22).
Consistent with previous crystal structures, the
wild-type protein shows remarkably little ﬂexibility as
seen by the majority of residues having S2 values of
>0.85 (Figure 2D–G). The majority of residues within
the core secondary structure of 6 E2 could be ﬁtted to
the simplest s2  c model indicative of a highly ordered
protein fold. There are, however, three regions of the
protein that show markedly different motional
properties. The N-terminus, as in many proteins, shows
a degree of increased ﬂexibility and these residues only
tended to ﬁt with the two-time-scale model. Second, the
b2/b3-loop, that is ordered in the 6 E2 DBD crystal
structures (although with higher than average tempera-
ture factors), appears partially disordered in solution, as
evidenced by pronounced reductions in S2 values for
loop residues and ﬁtting throughout the loop to the
two-time-scale model in the sub-nanosecond timescale
(Figure 2G). Several loop residues are missing data due
to the weak 1H-15N signals observed in this region and
the presence of two proline residues that are not detect-
able due to the absence of amide protons. These data
suggest that there may be some ordering of the 6 E2
b2/b3-loop upon DNA binding, although the tempera-
ture factors indicate that some disorder persists in the
complex. Finally the C-terminus which is buried in the
hydrophobic core of the protein does not show reduced
S2 values as seen in many protein dynamics studies with
ﬂexible C-termini. However, the reduced T2 values
measured for residues 361–368 requires the
S2  c  e  Rex models and a contribution from
slower (ms–ms) exchange motions (Rex, Figure 2F). The
size of the Rex term increases signiﬁcantly towards the
C-terminus.
Analysis of the E2LL relaxation data reveals that
many of the S2 values over the secondary structure
could only be satisfactorily ﬁt with the S2  c  e
model that incorporates fast motions and in general the
order parameters are marginally lower (Figure 2D).
Figure 3 shows the crystal structure of the DNA bound
form of 6 E2 (13). Residues in E2LL that show a large
reduction in S2 (>0.1) compared to 6 E2 are shown in
yellow while changes from 0.05 to 0.1 are shaded in
purple. Conversely, residues that that are more ordered
in E2LL are shaded in red. The largest concentration
of change, which shows an increase in ﬂexibility, is
centred around residues that can no longer pack against
the deleted terminal leucine residues at the core of the
dimeric barrel. The C-terminus, for example, shows a
loss of the slow conformational exchange observed in
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Figure 2. 1H-15N NMR relaxation data and graphical representation of dynamics parameters from the Lipari and Szabo model free analysis.
Elements of secondary structure for 6 E2 are shown above the graphs. Plots of (A) 15N-T1, (B)
15N-T2 and (C) NOE at 600MHz for 6 E2
(ﬁlled circles) and E2LL (open circles) are shown. Where data is not given for a residue the values of 15N-T1,
15N-T2 and NOE could not be
determined due to resonance overlap. (D) Plot of the dynamic order parameters derived from the Lipari and Szabo model free analysis (23,24), (E)
internal correlation times (te), (F) conformational exchange terms (Rex), (G) two-time-scale (ts) and (H) Amide exchange rates (10
6 s1). Where data
is not shown no rate could be measured due to the rate being too fast to observe or resonance overlap.
2974 Nucleic Acids Research, 2011, Vol. 39, No. 7
D
ow
nloaded from
 https://academ
ic.oup.com
/nar/article-abstract/39/7/2969/1142267 by U
niversity of N
ottingham
 user on 31 O
ctober 2018
wild-type 6 E2 being replaced instead with lower values of
S2 (assuming approximately the same overall topology
and monomer–dimer dissociation constant these are
most likely not due to anisotropic motion or monomer–
dimer exchange, respectively). Similarly the N-terminus
(i.e. S282 and S283) and central region (i.e. V288 and
Q289) of the b-barrel shows increased ﬂexibility, for
example both show reduced S2 values (Figure 3). Along
the sequence length several residues show notably reduced
S2 values, including G292, H320 and V333. G292 ﬁts a
two-time scale model indicative of an increase in
sub-nanosecond (but not picosecond) motions and
importantly connects b1 to the DNA binding helix a1.
Similarly H320 and V333 that ﬂank the b2/b3-loop both
show an increase in sub-nanosecond motions indicating
that the ﬂexibility in this loop now extends to incorporate
these residues at the edges of the b-barrel.
To complement the relaxation studies we measured
hydrogen/deuterium (H/D) exchange rates using
15N-labelled E2 and E2LL (Supplementary Figure S1).
In most cases, slow H/D exchange occurs when an amide
proton is involved in a hydrogen bond and an increased
exchange rate is observed upon localized or global protein
unfolding. For both proteins, the amide exchange rates fell
broadly into three categories, very fast, medium and slow
(Supplementary Table S1 and Figure 2H). Very fast
exchanging amides were not captured in either the 6 E2
or E2LL H/D exchange experiments and appear as gaps
in Figure 2H. These amides were almost all situated in the
loops connecting the secondary structure elements but are
regions that were well characterized by the relaxation
data. ‘Medium’ amide exchange rates ranging from 10 to
1000 (106 s1) were observed in helices a1 and a2 of both
forms with comparable rates with the exception of F300,
L304 and H308 that show 2- to 3-fold slower exchange in
the wild-type. Overall, however, this agrees with the relax-
ation data that suggests that the stability of the helical
elements shows little change between the proteins. The
remaining slow exchanging amides from 1 to 10 (106
s1) fall neatly throughout the ﬁrst and third b-strands
with the second b-strand showing a mixture of slow to
fast rates. However, exchange rate increases are
observed throughout the b-barrel for E2LL. This
broadly agrees with the dynamics data and suggests a
more pervasive loss of amide protection than is suggested
by the S2 values alone.
Both the relaxation and H/D exchange data probe the
dynamics of 6 E2 and E2LL over a wide range of
Figure 3. Changes in protein ﬂexibility in a truncated E2 DNA binding domain. The DNA bound form of the HPV 6 E2 DBD from PDB 2AYG
visualized using PyMOL (41). The protein and DNA backbones are shown in green and brown, respectively. The C-terminal amino acids L367 and
L368 are highlighted in orange. Protein residues that show reductions in S2 >0.1 are shown in yellow and reductions 0.05–0.1 are shown in purple.
Increases of S2 >0.05 are shown in red.
Nucleic Acids Research, 2011, Vol. 39, No. 7 2975
D
ow
nloaded from
 https://academ
ic.oup.com
/nar/article-abstract/39/7/2969/1142267 by U
niversity of N
ottingham
 user on 31 O
ctober 2018
timescales that reveal subtle changes in the mutant protein
consistent with increased mobility. Overall this leads to
the interpretation that—relative to the wild-type
protein—E2LL shows increased ﬂexibility in both the
b-barrel and longer range effects in the amino acids
ﬂanking the b2/b3-loop and connecting to the DNA
binding helix (Figure 3). The wider dynamic changes are
reminiscent of the global conformational changes that
occur in the HPV 16 E2 DBD when this protein binds
to DNA (15).
Increased protein ﬂexibility correlates with increased
DNA binding afﬁnity
To compare quantitatively the DNA binding activity of
the wild-type and mutated proteins, we performed gel
retardation assays with labelled E2 sites containing
either A:T rich or G:C rich spacer sequences (Figure 4A
and B). As expected from previous experiments (8,10), 6
E2 binds to an E2 site with an A:T rich spacer to produce
a retarded complex but binds very poorly to the same E2
site with a G:C rich spacer (Figure 4A). In contrast, the
E2LL protein is seen to bind signiﬁcantly to both oligo-
nucleotides, albeit with lower afﬁnity to the site with a
G:C rich spacer (Figure 4B). The amount of free and
bound DNA at each protein concentration was
determined in several independent experiments and
binding curves ﬁtted to the data (Figure 4C and D).
These binding curves were used to determine the
apparent equilibrium constant for each protein at these
sites (Table 1). The wild-type HPV 6 E2 DBD protein
binds to the A:T rich spacer site with an apparent equi-
librium constant of 41±13nM. This value is lower than
that we have previously reported (10), a difference likely
to be attributable to changes in the length of the oligo-
nucleotides used in the assays. The E2LL protein binds
to the same A:T rich spacer site around 2-fold more tightly
than the wild-type DBD, with an apparent equilibrium
constant of 22±7nM. The 6 E2 DBD binds to the G:C
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Figure 4. Speciﬁc DNA binding by the 6 E2 and E2LL proteins. (A) A representative gel retardation experiment showing the binding of 6 E2 to
labelled E2 binding sites with A:T rich or G:C rich spacer sequences. Lanes 1 and 8 contain no protein, lanes 2–7 contain 5, 12.5, 25, 62.5, 125 and
250 nM protein and lanes 9–14 contain 12.5, 25, 62.5, 125, 250 and 500 nM protein. Free and bound DNA were separated on a 6% polyacrylamide
gel and visualized using a PhosphorImager. (B) A representative gel retardation experiment showing the binding of E2LL to the labelled E2 binding
sites from (A). Lanes 1 and 8 contain no protein, lanes 2–7 contain 5, 12.5, 25, 62.5, 125 and 250 nM protein and lanes 9–14 contain 12.5, 25, 62.5,
125, 250 and 500 nM protein. Free and bound DNA were separated and visualized as above. (C) A graph showing the binding of E2 proteins to the
labelled E2 binding sites from (A). The amount of free and bound DNA was determined using a PhosphorImager and the percentage of labelled
DNA bound {[bound labelled DNA/(bound labelled DNA+free labelled DNA)] 100} is plotted against the amount of protein added. (D) A graph
showing the binding of E2LL to the labelled E2 binding sites from (A). Details as above.
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rich spacer site much less tightly than it does to the A:T
rich spacer site and in this case the afﬁnity is too low to be
determined accurately using this method. Similarly,
although it is apparent that E2LL binds to the G:C
rich spacer site with much higher afﬁnity than the
wild-type protein (Figure 4D), due to the weak binding
it is not possible to accurately determine the afﬁnity
from these data. However, since E2LL also shows
increased binding to the A:T rich spacer site, these data
suggest that increased protein ﬂexibility has increased
DNA binding afﬁnity without greatly changing the pref-
erence for an A:T spacer sequence over a G:C spacer
sequence.
We next compared the non-speciﬁc DNA binding
activity of these proteins. For these experiments, we
made use of a 195 bp DNA fragment that does not carry
a speciﬁc E2 binding site. When the 6 E2 DBD binds to
this DNA fragment it does not form a deﬁned retarded
complex but rather it produces a retarded smear (Figure
5A, lanes 2–5). This smearing is due to the dissociation of
weak, non-speciﬁc complexes during electrophoresis
(31,32). E2LL also binds to this non-speciﬁc DNA to
form a retarded smear (Figure 5A, lanes 6–9). However,
faint discrete retarded bands are formed at lower E2LL
concentrations, suggestive of more tightly bound
complexes (lanes 6 and 7) and lower protein concentra-
tions are required to shift all of the labelled DNA. To
compare the non-speciﬁc DNA binding activity of these
proteins in more detail we performed several repeats,
quantiﬁed the amount of free and bound DNA as
described above and determined the apparent equilibrium
constant (Figure 5B and Table 1). The non-speciﬁc DNA
binding activity of E2LL is around 10-fold higher that of
the wild-type protein (Table 1). The same results were
obtained using a second, unrelated non-speciﬁc
oligonucleotide (data not shown).
Taken together with the results of the speciﬁc DNA
binding assays (Figure 4) these results clearly show that
E2LL has increased DNA binding activity. However,
whereas speciﬁc binding has increased around 2-fold,
binding to non-speciﬁc DNA has increased around
10-fold, indicating that the overall DNA binding
speciﬁcity has decreased (Table 1) albeit without appear-
ing to alter the preference for an A:T spacer sequence.
This is clearly apparent from the 6-fold drop in ratio of
the dissociation constants for non-speciﬁc and speciﬁc
DNA given in Table 1. This is consistent with previous
data which has shown that ‘single chain’ HPV 16 E2 DBD
proteins with increased protein stability have increased
DNA binding speciﬁcity (33).
Structural rearrangements on DNA binding
We have previously described an analysis of the structural
rearrangements in the 6 E2 DBD that accompany DNA
binding in solution (13). As in the case of the HPV 16 E2
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Figure 5. Non-speciﬁc DNA binding activity of the 6 E2 and E2LL
proteins. (A) A representative gel retardation experiment showing the
binding of 6 E2 and E2LL to labelled 195 bp non-speciﬁc DNA
sequence. Lane 1 contains no protein, lanes 2–5 contain 0.25, 0.5,
0.75 and 1.0 mM E2 and lanes 6–9 contain 0.25, 0.5, 0.75 and 1.0 mM
E2LL. Free and bound DNA were separated and visualized as
described in Figure 4. (B) A graph showing the binding of E2 and
E2LL to the labelled non-speciﬁc DNA from (A). The amount of
free and bound DNA was determined using a PhosphorImager and
the percentage of labelled DNA bound {[bound labelled DNA/
(bound labelled DNA+free labelled DNA)] 100} is plotted against
the amount of protein added.
Table 1. Binding of E2 and E2LL to speciﬁc and non-speciﬁc
DNA
6E2
KeqðappÞa
ðnMÞ
6E2LL
KeqðappÞ
ðnMÞ
E2 site A:T spacer 41±13 22±7
Non-speciﬁc DNA 1203±437 110±25
Speciﬁcityb 29.4 5.0
aThe apparent equilibrium constant (Keq(apparent)) was obtained using
the equation:
[boundDNA]= [maximum boundDNA] [protein]/([protein]+Keq(app))
When [DNA] is much less than the Keq, the apparent equilibrium
constant is equal to the protein concentration at half maximum
DNA binding. The values shown are derived from ﬁve independent
experiments.
bThe speciﬁcity is the ratio of non-speciﬁc to speciﬁc binding (42):
Speciﬁcity=Keq(app)
non-speciﬁc DNA/Keq(app)
speciﬁc A:T spacer.
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DBD (34), the change in ﬂuorescence of protein trypto-
phan residues associated with complex formation
indicates that DNA binding occurs in two distinct
phases: a faster interaction presumed to be non-speciﬁc
and diffusion-limited and a slower interaction that is
thought to be a result of protein rearrangements during
formation of the speciﬁc complex (34,35). In order to
compare the DNA binding kinetics of 6 E2 and E2LL
we analysed intrinsic ﬂuorescence during complex forma-
tion with an E2 site containing an A:T rich spacer exactly
as described previously (13). Representative data are
shown in Figure 6 and the rate constants derived from
the data are shown in Table 2. Both proteins show an
increase in the amplitude of ﬂuorescence with increasing
A:T spacer DNA concentration. The association data
were ﬁtted to a double exponential curve to derive the
fast and slow rates in each case and the rates were
plotted against DNA concentration. Similar to the
previous results with wild-type HPV 16 E2, the fast rate
for E2LL binding increases with DNA concentration,
while the slow rate remain relatively constant as DNA
concentration is increased (Figure 6B). The slow rates
for 6 E2 and E2LL are very similar, suggesting that in
each case the rearrangements occurring during formation
of the tight-binding complex are not signiﬁcantly different
(Table 2). However, the initial fast rate for the association
of E2LL is increased by around 10-fold compared to the
wild-type protein. The off-rate is also increased, but only
around 2-fold. Together these differences indicate about a
5-fold increase in binding to DNA. The differences in
initial binding to the A:T spacer DNA are very unlikely
to be due to differences in the electrostatic surfaces of the
two proteins since these are unchanged by the mutation.
These data therefore suggest that the so-called initial
complex formed by the wild-type protein is not a
diffusion-limited encounter complex rather it is a second-
ary complex that forms after the encounter complex
(as indicated in the model shown in Figure 7, E2).
Increasing the ﬂexibility of the E2 DBD appears to facili-
tate formation of this secondary complex and we presume
that it then becomes diffusion-limited (Figure 7, E2LL).
Increased ﬂexibility has little or no effect on the structural
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Figure 6. Kinetic association data. (A) Typical stopped-ﬂow ﬂuores-
cence data for 2 mM E2 DBD and 0.25 mM A:T rich site. A minimum
of 10 curves were averaged to minimize noise. The raw data (displayed
in blue) was ﬁtted to either a double exponential curve (red line) or to a
single exponential curve (dashed line). The double exponential curve
correlates well with the data. (B) The rates obtained from the double
exponential curves ﬁtted to the raw data as shown above were plotted
against the DNA concentration. A straight line could be ﬁtted to the
fast rate (dotted line) and slow rate (solid line).
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Figure 7. A model for the E2-DNA complex formation. A schematic
representation of the binding of 6 E2 and E2LL to DNA. E2 dimers
(open squares) bind to DNA to form a diffusion limited encounter
complex. This subsequently forms a secondary complex (shaded
circles) which in turn undergoes further structural rearrangement to
form the ﬁnal tightly bound complex (ﬁlled circles). We propose that
the increased protein ﬂexibility shown by E2LL (open circles) facili-
tates formation of the secondary complex but has little or no effect on
the following step. Formation of the secondary complex for E2LL is
then diffusion limited.
Table 2. Kinetic data for E2- and E2LL–DNA complex formation
obtained using stopped-ﬂow ﬂuorescence experiments
Fast rate Slow rate
k1 on (M
1 s1) k1 off (s
1) k2 (s
1)
HPV 6 E2 (9.2±0.8) 107 68±16 29±6
HPV 6 E2LL (1.0±0.1) 109 182±33 44±18
The k1 on and k1 off of the fast rate were obtained from the slope and
intercept with the y-axis of the graph shown in Figure 6. The k2 value
was obtained from the slope of the slow rate on the same graph. The
values for HPV 6 E2 are from previously published data (13).
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rearrangements that follow and are required in order to
form the ﬁnal complex. Pre-bent DNA might facilitate
formation of the initial complexes although it would
seem more likely that it facilitates the protein structural
rearrangements that produce the ﬁnal complex. However,
it is important to note that clariﬁcation of this point would
require kinetic data with the G:C spacer DNA and we
were unable to obtain this information due to the
weakness of the interaction of both proteins with this
DNA. In sum our data are not inconsistent with a
model for DNA binding proposed by Ferreiro and de
Prat-Gay (34) in which the E2 DBD is proposed to exist
in two populations which bind DNA through different
pathways. In one state, E2 binds preferentially to
pre-bent DNA and then undergoes structural rearrange-
ments resulting in tight binding. However, another popu-
lation of E2 proteins bind to both pre-bent and non-bent
DNA to form directly the ﬁnal complex. The increased
binding afﬁnity correlated with increased DBD ﬂexibility
could arise from a greater proportion of the protein being
present in the second population.
CONCLUSIONS
Many protein–DNA complexes contain bent or otherwise
deformed DNA and the importance of DNA ﬂexibility in
DNA recognition has long been recognized and studied
intensively (10,13,36–38). Similarly, although less
well-studied, protein adaptability can also generate or
favour the formation of speciﬁc interactions and thereby
increase binding (39,40). In contrast, reduced protein
movement in the complex would be expected to diminish
this ﬁne-tuning of complementarity, and impart an
entropic cost to the interaction thereby weakening
binding. Here we have shown that the HPV 6 E2 DBD
has very low intrinsic ﬂexibility in solution. We have also
shown that by altering the overall and inter-domain
protein ﬂexibility of the HPV 6 E2 DBD, unusually via
partial disruption of the hydrophobic core of the protein,
both non-speciﬁc and speciﬁc DNA binding can be
improved. In this instance increased protein adaptability
appears to dominate binding, overcoming the expected
entropic cost normally associated with freezing a more
mobile protein in a bound complex. These surprising
results suggest that engineering of domain associations
in 2-fold symmetric dimers—commonly found in DNA
binding proteins—may provide an elegant route to
increased binding. Changes that shift the dimeric E2
binding surface towards the conformation observed in
its DNA complexes would generally be expected to be
favourable for binding. Improved protein adaptability
has a greater effect on non-speciﬁc DNA binding, suggest-
ing that it could mimic protein conformation changes that
occur during non-speciﬁc interactions.
We also note that increasing the adaptability of the
HPV 6 E2 DBD does not appear to alter its capacity for
indirect readout. These data suggest that in this case
limited protein ﬂexibility is not responsible for indirect
readout of DNA conformation. Presumably the entropic
cost associated with restricting E2 to a conformation best
suited to DNA binding is not signiﬁcant compared to the
overall energy change brought about by speciﬁc binding.
In support of this conclusion, our stopped-ﬂow kinetic
studies show that increased protein ﬂexibility has little
or no effect on the structural rearrangements that follow
initial binding. However, increased protein ﬂexibility has a
major effect on DNA binding speciﬁcity, signiﬁcantly
decreasing the preference for speciﬁc DNA over
non-speciﬁc DNA. This result is not inconsistent with
converse ﬁndings by Prat-Gay and co-workers who have
previously shown that ‘single chain’ HPV 16 E2 DBD
proteins with increased protein stability have decreased
non-speciﬁc DNA binding and increased speciﬁc binding
(33). The effect of the linker chain on protein adaptability
in this engineered form of E2 is not clear, but might be
expected to limit conformational changes. The restricted
adaptability of the HPV 6 E2 DBD is, therefore, likely to
be of primary importance for the ability of this protein to
locate its speciﬁc target sites in the viral genome in the
presence of a vast excess of host genomic DNA.
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